|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.58 USD | +0.64% |
|
-.--% | -3.90% |
| 01-23 | Astria Therapeutics, Inc. Announces Board Resignations | CI |
| 01-23 | BioCryst Pharmaceuticals, Inc. completed the acquisition of Astria Therapeutics, Inc. from group of shareholders. | CI |
| Market Cap | 747M 649M 605M 556M 1.05B 71.08B 1.06B 7.13B 2.79B 35.53B 2.81B 2.74B 118B | P/E 2025 * |
-
| P/E 2026 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 424M 369M 344M 316M 597M 40.38B 604M 4.05B 1.58B 20.18B 1.59B 1.56B 66.88B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
99.99% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Astria Therapeutics, Inc.
| 1 day | +0.64% | ||
| Current year | -3.90% |
| Current year | 12.24 |  | 13.28 |
| 1 year | 6.06 | | 13.29 |
| 3 years | 3.56 | | 16.9 |
| 5 years | 2.36 | | 16.9 |
| 10 years | 2.36 | | 473.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Babar Ghias
PSD | President | 47 | 2026-01-22 |
Alane Barnes
SEC | Corporate Secretary | 60 | 2026-01-22 |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Babar Ghias
BRD | Director/Board Member | 47 | 2026-01-22 |
Alane Barnes
BRD | Director/Board Member | 60 | 2026-01-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/23/26 | Issuer sale | Director | 54,750 | 0.0959% | ||
| 1/23/26 | Issuer sale | Director | 79,749 | 0.1397% | ||
| 1/23/26 | Issuer sale | Chief Financial Officer | 317,500 | 0.5562% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.64% | -.--% | +91.77% | +44.10% | 718M | |
| +10.00% | +13.39% | +51.99% | +83.45% | 56.7B | |
| +0.80% | -5.70% | +23.89% | +62.65% | 51.97B | |
| -0.78% | -1.08% | -16.89% | -14.12% | 23.33B | |
| +0.02% | -5.51% | -11.55% | +347.43% | 21.34B | |
| +1.73% | -1.57% | +32.81% | -25.80% | 17.44B | |
| +4.29% | +1.67% | +201.24% | +344.48% | 14.77B | |
| +1.84% | -1.00% | +51.98% | +176.00% | 13.84B | |
| +3.04% | +4.08% | +442.24% | +182.09% | 12.12B | |
| +5.71% | -5.43% | +63.25% | +162.00% | 11.14B | |
| Average | +2.76% | -0.56% | +93.07% | +136.23% | 22.34B | |
| Weighted average by Cap. | +3.65% | +0.44% | +62.42% | +117.25% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -123M -107M -99.38M -91.3M -173M -11.68B -175M -1.17B -458M -5.84B -461M -451M -19.34B | - |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ATXS Stock
Select your edition
All financial news and data tailored to specific country editions
